Dr. David Granville, viDA CSO, to Present at Society for Leukocyte Biology 50th Annual Meeting
Granville Laboratory Receives Inaugural Michael Smith Foundation for Health Research Innovation to Commercialization (I2C) Award
viDA Therapeutics Inc. Appoints Orphan Product RegulatoryExecutive Dr. Marlene Haffner to Board of Directors
viDA Therapeutics Inc. Announces Appointment of New Chair of the BoardDr. Ron Nardi joins viDA Therapeutics Science Advisory Board
viDA Therapeutics Inc. appoints orphan product executive to Board of Directors
Database update underway. Please see Granzymes.com.